Published in Am J Trop Med Hyg on June 01, 2005
Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med (2016) 2.15
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int J Parasitol (2010) 1.15
Cysticercosis of the central nervous system: how should it be managed? Curr Opin Infect Dis (2011) 1.09
Vaccination with recombinant oncosphere antigens reduces the susceptibility of sheep to infection with Taenia multiceps. Int J Parasitol (2007) 0.99
Monitoring the outcomes of interventions against Taenia solium: options and suggestions. Parasite Immunol (2016) 0.94
Geographic correlation between tapeworm carriers and heavily infected cysticercotic pigs. PLoS Negl Trop Dis (2012) 0.94
Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr (2009) 0.93
Prevention and control of Taenia solium taeniasis/cysticercosis in Peru. Pathog Glob Health (2012) 0.89
Protection of pigs against Taenia solium cysticercosis by immunization with novel recombinant antigens. Vaccine (2012) 0.87
Successful immunization of naturally reared pigs against porcine cysticercosis with a recombinant oncosphere antigen vaccine. Vet Parasitol (2012) 0.86
Validity of the Enzyme-linked Immunoelectrotransfer Blot (EITB) for naturally acquired porcine cysticercosis. Vet Parasitol (2013) 0.85
Antibody responses to the host-protective Taenia solium oncosphere protein TSOL18 in pigs are directed against conformational epitopes. Parasite Immunol (2010) 0.83
Cysticercosis control: bringing advances to the field. J Glob Infect Dis (2011) 0.83
Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment. Clin Microbiol Rev (2014) 0.83
Characterization of a novel Taenia solium oncosphere antigen. Mol Biochem Parasitol (2007) 0.82
TSOL18/HP6-Tsol, an immunogenic Taenia solium oncospheral adhesion protein and potential protective antigen. Parasitol Res (2008) 0.81
The Taenia saginata homologue of the major surface antigen of Echinococcus spp. is immunogenic and 97% identical to its Taenia solium homologue. Parasitol Res (2007) 0.80
Heterologous prime-boost oral immunization with GK-1 peptide from Taenia crassiceps cysticerci induces protective immunity. Clin Vaccine Immunol (2011) 0.80
New insights in cysticercosis transmission. PLoS Negl Trop Dis (2014) 0.80
Managing neurocysticercosis: challenges and solutions. Int J Gen Med (2015) 0.79
The present situation and towards the prevention and control of neurocysticercosis on the tropical island, Bali, Indonesia. Parasit Vectors (2015) 0.79
Characterization of S3Pvac anti-cysticercosis vaccine components: implications for the development of an anti-cestodiasis vaccine. PLoS One (2010) 0.78
Immunoinformatics prediction of linear epitopes from Taenia solium TSOL18. Bioinformation (2011) 0.78
Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells. Planta (2015) 0.77
Immunolocalization of TSOL18 and TSOL45-1A, the successful protective peptides against porcine cysticercosis, in Taenia solium oncospheres. Parasit Vectors (2011) 0.75
The highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigs. Vet Immunol Immunopathol (2011) 0.75
Verifying elimination programs with a special emphasis on cysticercosis endpoints and postelimination surveillance. J Parasitol Res (2012) 0.75
Vaccine development against the Taenia solium parasite: the role of recombinant protein expression in Escherichia coli. Bioengineered (2012) 0.75
Assessing the impact of intervention strategies against Taenia solium cysticercosis using the EPICYST transmission model. Parasit Vectors (2017) 0.75
CystiSim - An Agent-Based Model for Taenia solium Transmission and Control. PLoS Negl Trop Dis (2016) 0.75
Neurocysticercosis: a review on status in India, management, and current therapeutic interventions. Parasitol Res (2016) 0.75
Human taeniasis: current insights into prevention and management strategies in endemic countries. Risk Manag Healthc Policy (2017) 0.75
Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis (2003) 15.02
Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med (2006) 8.39
Taenia solium cysticercosis. Lancet (2003) 5.89
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA (2007) 5.22
Human brucellosis. Lancet Infect Dis (2007) 4.92
Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Lancet (2002) 4.90
Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol (2008) 4.46
Effect of water and sanitation on childhood health in a poor Peruvian peri-urban community. Lancet (2004) 4.36
Natural ventilation for the prevention of airborne contagion. PLoS Med (2007) 3.73
The effect of deforestation on the human-biting rate of Anopheles darlingi, the primary vector of Falciparum malaria in the Peruvian Amazon. Am J Trop Med Hyg (2006) 3.72
Prevention and control of cystic echinococcosis. Lancet Infect Dis (2007) 3.64
Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev (2002) 3.37
Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J Clin Microbiol (2004) 3.27
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Update on the human broad tapeworm (genus diphyllobothrium), including clinical relevance. Clin Microbiol Rev (2009) 2.78
Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis (2005) 2.75
Diagnostic approaches for paediatric tuberculosis by use of different specimen types, culture methods, and PCR: a prospective case-control study. Lancet Infect Dis (2010) 2.69
Linking deforestation to malaria in the Amazon: characterization of the breeding habitat of the principal malaria vector, Anopheles darlingi. Am J Trop Med Hyg (2009) 2.64
Triosephosphate isomerase gene characterization and potential zoonotic transmission of Giardia duodenalis. Emerg Infect Dis (2003) 2.46
Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg (2003) 2.43
Species identification after treatment for human taeniasis. Lancet (2004) 2.43
Multiple norovirus infections in a birth cohort in a Peruvian Periurban community. Clin Infect Dis (2013) 2.37
The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model. Clin Infect Dis (2007) 2.28
Diagnosis and treatment of neurocysticercosis. Nat Rev Neurol (2011) 2.20
Pulmonary cystic echinococcosis. Curr Opin Pulm Med (2010) 2.20
Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy. Clin Infect Dis (2010) 2.11
Neurocysticercosis: A natural human model of epileptogenesis. Epilepsia (2014) 2.11
New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg (2005) 2.10
The infectiousness of tuberculosis patients coinfected with HIV. PLoS Med (2008) 2.08
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru. Am J Trop Med Hyg (2006) 2.05
Can the power of mobile phones be used to improve tuberculosis diagnosis in developing countries? Trans R Soc Trop Med Hyg (2008) 2.01
Environmental exposure and leptospirosis, Peru. Emerg Infect Dis (2004) 1.96
Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis (2008) 1.96
Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe (2009) 1.96
Determining risk for severe leptospirosis by molecular analysis of environmental surface waters for pathogenic Leptospira. PLoS Med (2006) 1.92
Effects of acute diarrhea on linear growth in Peruvian children. Am J Epidemiol (2003) 1.90
Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis (2008) 1.87
Periurban Trypanosoma cruzi-infected Triatoma infestans, Arequipa, Peru. Emerg Infect Dis (2006) 1.85
Epilepsy in poor regions of the world. Lancet (2012) 1.85
Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clin Infect Dis (2009) 1.81
Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics (2006) 1.74
Fecal contamination of drinking water within peri-urban households, Lima, Peru. Am J Trop Med Hyg (2007) 1.72
Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis (2002) 1.72
Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Assist Tomogr (2005) 1.67
Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia (2005) 1.65
Upper-room ultraviolet light and negative air ionization to prevent tuberculosis transmission. PLoS Med (2009) 1.64
Cystic echinococcosis: chronic, complex, and still neglected. PLoS Negl Trop Dis (2011) 1.61
Transposable element ISHp608 of Helicobacter pylori: nonrandom geographic distribution, functional organization, and insertion specificity. J Bacteriol (2002) 1.60
Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis. J Infect Dis (2004) 1.60
Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart (2011) 1.60
Ethics review procedures for research in developing countries: a basic presumption of guilt. CMAJ (2004) 1.60
Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons. Clin Infect Dis (2010) 1.60
Diagnosis of sputum-scarce HIV-associated pulmonary tuberculosis in Lima, Peru. Lancet (2005) 1.57
Hyperendemic human and porcine Taenia solium infection in Perú. Am J Trop Med Hyg (2003) 1.56
Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin Infect Dis (2002) 1.56
Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect Immun (2004) 1.56
Vaccines to combat the neglected tropical diseases. Immunol Rev (2011) 1.55
Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55
Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54
Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis (2007) 1.53
Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis. Am J Trop Med Hyg (2009) 1.53
Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open (2012) 1.52
Helicobacter Pylori's plasticity zones are novel transposable elements. PLoS One (2009) 1.48
Helicobacter pylori from Peruvian amerindians: traces of human migrations in strains from remote Amazon, and genome sequence of an Amerind strain. PLoS One (2010) 1.48
The effect on cardiovascular risk factors of migration from rural to urban areas in Peru: PERU MIGRANT Study. BMC Cardiovasc Disord (2009) 1.46
Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res (2014) 1.44
Tetrazolium microplate assay as a rapid and inexpensive colorimetric method for determination of antibiotic susceptibility of Mycobacterium tuberculosis. J Clin Microbiol (2002) 1.43
Epidemiologic differences between cyclosporiasis and cryptosporidiosis in Peruvian children. Emerg Infect Dis (2002) 1.43
Socio-demographics and the development of malaria elimination strategies in the low transmission setting. Acta Trop (2011) 1.43
Cysticerci-related single parenchymal brain enhancing lesions in non-endemic countries. J Neurol Sci (2012) 1.42
Chagas disease transmission in periurban communities of Arequipa, Peru. Clin Infect Dis (2008) 1.40
Effects of nutritional status on diarrhea in Peruvian children. J Pediatr (2002) 1.39
Geographic variation in the sensitivity of recombinant antigen-based rapid tests for chronic Trypanosoma cruzi infection. Am J Trop Med Hyg (2009) 1.38
Human caliciviruses as a cause of severe gastroenteritis in Peruvian children. J Infect Dis (2004) 1.37
Identification of the cryptosporidium pig genotype in a human patient. J Infect Dis (2002) 1.36
Cryptosporidium species and genotypes in HIV-positive patients in Lima, Peru. J Eukaryot Microbiol (2003) 1.34
The epidemiology of intestinal microsporidiosis in patients with HIV/AIDS in Lima, Peru. J Infect Dis (2005) 1.33